Home
/
RxSight, Inc.
/
Financials
/
Quarterly
RxSight, Inc. — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that RxSight, Inc. filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$30.34M
Nov 5, 2025
Q2
2025
Jun 30, 2025
$33.64M
Aug 7, 2025
Q1
2025
Mar 31, 2025
$37.90M
May 7, 2025
Q3
2025
Sep 30, 2024
$35.31M
Nov 5, 2025
Q2
2025
Jun 30, 2024
$34.89M
Aug 7, 2025
Q1
2025
Mar 31, 2024
$29.51M
May 7, 2025
Q3
2024
Sep 30, 2023
$22.20M
Nov 7, 2024
Q2
2024
Jun 30, 2023
$20.81M
Aug 5, 2024
Q1
2024
Mar 31, 2023
$17.49M
May 6, 2024
Q3
2023
Sep 30, 2022
$12.62M
Nov 9, 2023
Q2
2023
Jun 30, 2022
$11.36M
Aug 7, 2023
Q1
2023
Mar 31, 2022
$8.94M
May 9, 2023
Q3
2022
Sep 30, 2021
$5.79M
Nov 7, 2022
Q2
2022
Jun 30, 2021
$4.90M
Aug 8, 2022
Q1
2022
Mar 31, 2021
$3.48M
May 5, 2022
Q3
2021
Sep 30, 2020
$4.17M
Nov 10, 2021
Q2
2021
Jun 30, 2020
$2.71M
Sep 9, 2021
Net Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($9.82M)
Nov 5, 2025
Q2
2025
Jun 30, 2025
($11.79M)
Aug 7, 2025
Q3
2025
Jun 30, 2025
($11.79M)
Nov 5, 2025
Q2
2025
Mar 31, 2025
($8.19M)
Aug 7, 2025
Q1
2025
Mar 31, 2025
($8.19M)
May 7, 2025
Q3
2025
Mar 31, 2025
($8.19M)
Nov 5, 2025
Q3
2025
Sep 30, 2024
($6.34M)
Nov 5, 2025
Q3
2025
Jun 30, 2024
($6.08M)
Nov 5, 2025
Q2
2025
Jun 30, 2024
($6.08M)
Aug 7, 2025
Q2
2025
Mar 31, 2024
($9.10M)
Aug 7, 2025
Q1
2025
Mar 31, 2024
($9.10M)
May 7, 2025
Q3
2025
Mar 31, 2024
($9.10M)
Nov 5, 2025
Q3
2024
Sep 30, 2023
($12.42M)
Nov 7, 2024
Q3
2024
Jun 30, 2023
($13.80M)
Nov 7, 2024
Q2
2024
Jun 30, 2023
($13.80M)
Aug 5, 2024
Q3
2024
Mar 31, 2023
($13.21M)
Nov 7, 2024
Q1
2024
Mar 31, 2023
($13.21M)
May 6, 2024
Q2
2024
Mar 31, 2023
($13.21M)
Aug 5, 2024
Q3
2023
Sep 30, 2022
($16.82M)
Nov 9, 2023
Q3
2023
Jun 30, 2022
($16.73M)
Nov 9, 2023
Operating Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($12.18M)
Nov 5, 2025
Q2
2025
Jun 30, 2025
($14.00M)
Aug 7, 2025
Q1
2025
Mar 31, 2025
($10.67M)
May 7, 2025
Q3
2025
Sep 30, 2024
($9.23M)
Nov 5, 2025
Q2
2025
Jun 30, 2024
($8.33M)
Aug 7, 2025
Q1
2025
Mar 31, 2024
($10.67M)
May 7, 2025
Q3
2024
Sep 30, 2023
($12.51M)
Nov 7, 2024
Q2
2024
Jun 30, 2023
($13.63M)
Aug 5, 2024
Q1
2024
Mar 31, 2023
($13.10M)
May 6, 2024
Q3
2023
Sep 30, 2022
($15.96M)
Nov 9, 2023
Q2
2023
Jun 30, 2022
($15.79M)
Aug 7, 2023
Q1
2023
Mar 31, 2022
($16.58M)
May 9, 2023
Q3
2022
Sep 30, 2021
($13.11M)
Nov 7, 2022
Q2
2022
Jun 30, 2021
($13.88M)
Aug 8, 2022
Q1
2022
Mar 31, 2021
($11.14M)
May 5, 2022
Q3
2021
Sep 30, 2020
($8.91M)
Nov 10, 2021
Q2
2021
Jun 30, 2020
($8.81M)
Sep 9, 2021